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Abstract
The chronic over-activation of the endogenously produced cannabinoids in obesity has been demonstrated in several studies. 
A common 385C>A single nucleotide polymorphism of the fatty acid amide hydrolase, one the most important inactivat-
ing enzymes of endogenous cannabinoids, has been shown to be associated with obese phenotype. This study was designed 
to investigate the FAAH gene polymorphisms and to compare the obesity indices between different genotypes in Iranian 
overweight/obese women. A total of 180 healthy overweight/obese subjects (BMI = 25 to 40 kg/m2) and 86 normal weight 
individuals (BMI = 18.5 to 24.9 kg/m2) were genotyped for 385 C/A polymorphism of FAAH using amplification refractory 
mutation system (ARMS)-PCR. Anthropometric indices including BMI, waist circumference, neck circumference, waist 
to height ratio, fat mass were evaluated. A written informed consent form was given by the participants. The genotype and 
allele frequencies were significantly different between the overweight/obese and control groups (P = 0.04). Significant differ-
ences were observed between the CC genotype and the AA+CA genotype regarding the anthropometric indices (P < 0.05). 
Compared to CC group, a higher BMI, WC, WHtR, NC and fat mass was identified in allele A carriers group. After adjusting 
for age, marital and physical activity status, it was revealed that having the CA/AA genotype increased the probability of 
obesity risk almost two times (P < 0.05, 95% CI 1.19–3.67). Our findings showed that the frequency of A allele was greater 
in overweight/obese individuals. Also, a mutation in FAAH gene was associated with higher anthropometric indices and the 
CA/AA genotype increased significantly the possibility of being obese in Iranian women.
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Introduction
Obesity has become one of the most important health chal-
lenges in the last decades and its prevalence is worsening 
throughout the world [1]. It is projected that if secular trends 
continue, approximately 38% of the world’s adult population 
will be overweight and 20% will be obese by 2030 [2]. Com-
parable to the developed countries, in developing countries 
the obesity rate has also tripled during the past years [3]. 
Iran is also one of the developing countries in which the 
obesity rate has elevated at an alarming speed and approxi-
mately 23.3% of the Iranian adults are obese [4]. Obesity 
provokes or exacerbates a number of pathologies alone or in 
conjunction with other health issues [5, 6]. Obesity mainly 
accounts for the incidence of several chronic diseases includ-
ing cardiovascular disease, type two diabetes, and different 
types of cancers [7–9].
In addition to the role of environmental factors in over-
weight and obesity spread, previous reports has repeatedly 
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emphasized that genetic factors play significant role in sev-
eral adiposity traits, such as BMI, waist circumference, vis-
ceral and subcutaneous adipose tissue, and etc. [10–12]. It is 
believed that genetic factors and polymorphisms in related 
genes are currently responsible for 40–70% of the variance 
in human adiposity [13]. In the last few decades, the genes 
and molecules which are responsible for energy intake regu-
lation have been spotted and studied widely [14–16].
Endogenous cannabinoids are lipid molecules produced 
from phospholipids or triglycerides of the membrane with 
several effects on metabolic regulation and body weight 
[17]. Different enzymes get involved in the synthesis and 
degradation of the two most significant endocannabinoids, 
anandamide (AEA) and 2-arachidonoyl glycerol (2-AG) 
[18]. Fatty acid amide hydrolase (FAAH) has been known 
as the key catabolic enzyme, capable of deactivating most 
of the endocannabinoids including AEA [19]. FAAH is a 
serine hydrolase and a missense c.385C>A single-nucleo-
tide polymorphism (SNP) (rs324420) in the human FAAH 
gene replaces a conserved proline residue at amino acid 
position 129 to threonine [20]. This replacement can lead 
to a decrease in FAAH expression or activity, resulting in 
continued stimulation of the cannabinoid 1 receptor through 
the increased levels of the endogenous fatty acid amides 
which in turn increase appetite, food intake and body fat 
accumulation [21].
Although genetic variation in FAAH particularly the 
homozygous FAAH 385 A/A genotype has formerly been 
shown to be associated with overweight and obesity [22–24], 
others have failed to find such association [25, 26]. Addition-
ally, there is scarcity of studies about the relation of FAAH 
gene polymorphisms with obese phenotypes in the Asian 
population. To this end, since determining of the common 
genetic variants that affect obesity risk at a population level 
might improve the pathophysiologic conception of obe-
sity, this study was designed to evaluate the FAAH gene 
polymorphisms status and to compare the obesity indices 
between different genotypes in Iranian overweight/obese 
women.
Subjects and methods
Participants and study design
This cross-sectional study was carried out between October 
2017 and January 2018. The study protocol was approved 
by local ethical committee (IR.TBZMED.REC.1396.620) 
and all the participants consented to use their genetic mate-
rial and other necessary information. A total of 180 healthy 
overweight/obese subjects (BMI = 25 to 40 kg/m2) and 86 
normal weight individuals (BMI = 18.5 to 24.9 kg/m2) were 
enrolled in this study and all the participants were collected 
from the same geographical area. Since the obesity rate and 
food craving is more prevalent among women, we carried 
out this research only among women. Those having history 
of any metabolic disorders such as diabetes, kidney and 
liver disease as well as pregnant and lactating women were 
excluded. The demographic and physical activity informa-
tion of the participants was recorded using the appropriate 
questionnaire by trained dietitian. The individuals’ physi-
cal activity was evaluated using the International Physical 
Activity Questionnaire (IPAQ).
Anthropometric and body composition
The measurement of anthropometric indices including 
weight, height, waist circumference (WC), neck circumfer-
ence (NC), and blood pressure were carried out in line with 
standard protocols in fasting state [27, 28]. By dividing WC 
by height the waist-to-height ratio (WHtR) was determined. 
BMI was calculated as weight (kg) divided by the square 
of the height  (m2). Fat mass was evaluated by bioelectrical 
impedance analysis (BC-418MA, Tanita, Japan).
DNA extraction and genotyping
Fasting venous blood samples were collected for genotyp-
ing process. The genomic DNA extraction from peripheral 
blood cell was carried out using DNA extraction and puri-
fication kit (Qiagen, Cat No./ID: 51306) as manufacturer’s 
protocol. Optical density measurement (quantitative method 
based) was used to determine the genomic DNA concen-
tration. By calculating the absorbance ratio at 260 nm to 
absorbance at 280 nm (A260/A280) the samples purity was 
confirmed. The genotyping was carried out by the amplifi-
cation refractory mutation system (ARMS)-PCR in which 
sequence-specific PCR primers allows amplification of test 
DNA only when the target allele is within the sample. The 
forward common primer 5′-GCC AGA GAC AGC CAG GAT 
GAGG-3′ and reverse primer 5′-ATA GAG CAG GCC CTG 
CCT TGG-3′ were used to amplify a 314 bp product to detect 
the wild types. Also, the forward common primer 5′-GCC 
AGA GAC AGC CAG GAT GAGG-3′ together with reverse 
primer 5′-ATA GAG CAG GCC CTG CCT TGT-3′ were used 
to amplify and detect 314 bp mutant forms. Moreover, to 
confirm the accuracy of PCR results and to spot any nega-
tive results on agarose gel Hemoglobin (Hb) primers with 
the following sequences were used as internal controls 
(110 bp). Hb Forward: 5′-ACA CAA CTG TGT TCA CTA 
GC-3′, Hb Reverse: 5′-CAA CTT CAT CCA CGT TCA CC-3′ 
Fig. 1. The PCR reaction was performed in a total reaction 
volume of 30 µl as previously described [11]. The optimiza-
tion was carried out and thermo cycler conditions were as 
follows: the initial denaturation at 96 °C for 5 min followed 
by 35 cycles of amplification, each cycle consisting of 30 s 
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at 96 °C, 62 s at 30 °C and 45 s at 72 °C, in in a peqlab PCR 
system. The reaction completed with a one more 7 min of 
extension at 72 °C. PCR products were electrophoresed on 
1% agarose gel containing 5 μl/dl safe stain (Cinna Gen Co., 
Iran). Hardy–Weinberg equilibrium was evaluated.
Statistical analysis
Data were analyzed using SPSS software, version 21.0 (IBM 
Corp., Armonk, NY, USA). Normality of the data distribu-
tion was checked by the Kolmogorov–Smirnov goodness-of-
fit test. Values are presented as mean ± SD for variables with 
normal distribution or median (25th; 75th percentiles) for 
variables without normal distribution. The chi- square test 
and Fisher’s exact test were used to compare the FAAH 385 
C/A genotypes between overweight/obese group as group 
1 and control group as group 2. Two-tailed Student’s t test 
and Mann–Whitney U-test was used to analyze the quantita-
tive variables with normal distribution and nonparametric 
variables respectively. To predict the association of SNP 
with the risk of obesity logistic regression model was per-
formed. In all statistical analyses except for Fisher’s exact 
test, the C358A together with A358A were considered as a 
first group and wild type C358C as second group. To test 
the deviation of the observed genotype frequencies from the 
Hardy–Weinberg equilibrium (HWE), the Chi squared test 
was used in the overweight/obese and control samples. P 
value < 0.05 was regarded as statistically significant.
Results
The participants’ demographic, anthropometric, and labo-
ratory data are presented in Table 1. The study included 
180 overweight/obese (mean age 34.2 ± 8.27 years old; 133 
obese, 47 overweight) and 86 normal weight healthy women 
(mean age 33.1 years old ± 7.03). To test whether FAAH 
385 C/A genotypes frequencies differ between overweight/
obese and control group chi-square test and Fisher’s exact 
test were used. As presented in Table 2 the genotype and 
allele frequencies were significantly different between the 
overweight/obese and control groups (P = 0.04, fisher exact 
test). Compared to normal weight women, a greater distribu-
tion of the CA (n = 70) and AA (n = 6) genotypes and a lower 
Fig. 1  Agarose gel (1%) elec-
trophoresis for PCR products of 
FAAH C-385 A: Lane F,G; het-
erozygote C/A genotype, Lane 
B,C; homozygote C/C genotype, 
Lane D,E; homozygote A/A 
genotype, Lane H; 50 bp ladder, 
Lane O,P; positive control for 
C/A genotype, Lane K,L; posi-
tive control for homozygote C/C 
genotype, Lane M,N; positive 
control for homozygote A/A 
genotype, Lane A,I,J; negative 
control. 314 bp band; indicating 
C allele, 314 bp band; indicat-
ing A allele, 110 bp band; indi-
cating internal positive control
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distribution of the CC (n = 104) genotype was observed 
in overweight/obese group. Significant differences were 
observed between the homozygous genotype AA together 
with CA and wild homozygous CC regarding the anthro-
pometric indices including BMI, WC, WHtR, NC and fat 
mass (P < 0.05) (Table 3). In comparison to CC group, a 
higher BMI, WC, WHtR, NC and fat mass was identified 
in allele A careers group for the polymorphism 385C>A 
in FAAH. With respect to the logestic regression analysis, 
after adjusting for age, marital and physical activity status it 
was revealed that having the CA/AA genotype increased the 
probability obesity risk almost two times (P < 0.05, OR 2.28 
95% CI 1.19–3.67) (Table 4). In overweight/obese group, the 
54.4% of the individuals had low levels of activity, 39.4% 
were moderately active and the rest of them were highly 
active (6.1%). Similarly, in normal weight participants, 
the 94.2% of the subjects had low levels of activity, 3.5% 
and 2.3% of them had moderate and high levels of activity 
respectively. The distribution of the FAAH cDNA 385C to 
A genotypes in both overweight/obese women (P > 0.05) and 
healthy controls (P > 0.05) did not deviate from HWE.
Discussion
The chronic over-activation of the endogenously produced 
cannabinoids in obesity has been demonstrated in several 
studies [29–31]. A common 385C>A single nucleotide 
polymorphism (SNP) of the FAAH, one the most important 
degrading enzymes of endocannabinoids, leads to a mis-
sense mutation making a FAAH with defective expression 
[32].
Present study indicated that the minor 385A allele was 
more usual in the overweight/obese patients compared to 
normal weight women. In overweight/obese individuals, the 
AA genotype percentage (3.3%) was comparable with other 
studies, for instance; 3.7% [22], 2.3% [26], and 1% [24]. 
Also, the CA genotype percentage (38.89%) was almost 
identical with other papers; 24.1% [22], 28.1% [26], and 
36.5% [24]. The A allele of FAAH cDNA 385C to A SNP 
was also associated with a significant risk to develop obesity 
(OR 2.28, 95% CI 1.19–3.67). Moreover, BMI, WC, WHtR, 
NC and fat mass was higher in CA+AA group compared to 
individuals with CC genotypes.
The association of FAAH gene polymorphism and mutant 
allele carriers with obese phenotypes has been investigated 
in previous studies which yield contradictory results. In a 
study by Chiang et al. in 2004, it was reported that FAAH 
enzymatic activity and protein expression in FAAH 385 
A/A missense polymorphism individuals was almost half 
of the wild-type subjects [33]. Also, in Caucasian women 
cDNA 385 C to A missense polymorphism in the FAAH was 
associated with overweight/obesity but not with binge eating 
disorder according to Monteleone et al. [24]. Furthermore, 
poorer cardiovascular status (BMI, weight, WC, TNF-alpha, 
insulin, and adiponectin levels) has been found in obese 
Table 1  Participants’ demographic, anthropometric, and laboratory 
data
Values are presented as mean ± SD for variables with normal distribu-
tion or median (25th; 75th percentiles) for variables without normal 
distribution
BMI body mass index, WC waist circumference, NC neck circumfer-
ence, WHtR waist-to height ratio, SBP systolic blood pressure, DBP 
diastolic blood pressure, TC total cholesterol, LDL low-density lipo-
protein, HDL high-density lipoprotein, TG triglycerides (mg/dl), FBS 
fasting blood sugar
*Independent t test P value for differences between variables in con-
trol and overweight/obese group
**Mann–Whitney U test P value for differences between variables in 
control and overweight/obese group
Control
n = (86)
Overweight/obese
n = (180)
P-value
Age 33.19 ± 7.03 34.2 ± 8.27 > 0.05*
Weight (kg) 57.97 ± 6.53 83.41 ± 11.31 < 0.05*
Height (cm) 161.43 ± 5.80 159.95 ± 5.59 > 0.05*
BMI (kg/m2) 22.23 ± 2.08 32.54 ± 3.73 < 0.05*
WC (cm) 75 (69.75; 80) 101(95.25; 107) < 0.05**
NC (cm) 32 (30; 33) 38 (36; 40) < 0.05**
WHtR (cm) 0.46 (0.43; 0.49) 0.63 (0.59; 0.66) < 0.05**
Fat mass (kg) 16.28 ± 5.02 34.35 ± 7.68 < 0.05*
SBP (mmHg) 107 (98; 110) 113 (103.25; 122.75) < 0.05**
DBP (mmHg) 75 (69.75; 90) 77 (70; 82) > 0.05**
TC (mg/dl) 161.45 ± 33.82 171.68 ± 30.75 < 0.05*
LDL (mg/dl) 81.87 ± 28.14 97.41 ± 25.31 < 0.05*
HDL (mg/dl) 61.29 ± 9.41 49.93 ± 9.03 < 0.05*
TG (mg/dl) 82.5 (69; 101) 103.5 (78; 151.25) < 0.05**
FBS (mg/dl) 82 (76; 86) 89 (84; 99) < 0.05**
Insulin (IU/ml) 6 (5; 9) 25.2 (16.3; 34) < 0.05**
HOMA-IR 1.24 (0.98; 1.80) 5.56 (3.54; 7.99) < 0.05**
Table 2  Genotype and allele 
frequencies of the 385 C/A 
polymorphism of FAAH 
between overweight/obese 
subjects and control individuals
Fisher’s exact test value = 5.99, P-value = 0.04
Group n Genotype Allele
CC CA AA C A
Overweight/obese 180 104 (57.78%) 70 (38.89%) 6 (3.33%) 77.22% 22.77%
Control 86 63 (73.26%) 22 (25.58%) 1 (1.16%) 86.05% 13.95%
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minor A allele carrier [34]. However, in a 5801 of Dan-
ish population, no association existed between the FAAH A 
allele and BMI, WHR, WC, HOMA-IR [25]. Interestingly, 
there were other studies which revealed that the A allele has 
been associated with lower blood pressure, with improved 
cardiovascular profile and larger reduction in glucose, LDL, 
BMI, WC, triglycerides and total cholesterol under low fat 
and hypocaloric diet [35].
According to the evidence, half of the FAAH enzymatic 
activity and protein expression has been seen in minor A 
allele carriers in comparison to wild-type subjects leading 
to considerably elevated levels of AEA [36]. In a study by 
Sipe et al. carried out on 48 normal weight subjects (BMI 
of ≤ 26 kg/m2) and 96 severe obese individuals (BMI of 
≥ 40 kg/m2) significant elevation of AEA levels and similar 
substances in carriers of the FAAH 385 A mutant alleles 
were identified [22]. In another study, Martins et al. reported 
a remarkable association between increased AEA levels and 
the AA homozygous genotype in a multiethnic Brazilian 
population with a broad range of adiposity values [37]. We 
also noticed that AEA and 2-AG levels correlated positively 
with obesity indices including BMI, WC and BF% (data are 
not shown). Likewise, compared with their wild-type lit-
termates, FAAH–/– mice exhibited increased energy stor-
age [38]. AEA is one of the main endocannabinoids which 
can stimulate the CB1 receptor and has the capability of 
arousing appetite and feeding behavior which ultimately 
might promote the diet-induced obesity [39]. Addition-
ally, the FAAH A385A could trigger the up regulation of 
natural reward behaviors such as palatable and sweets food 
consumption related to overweight and obesity. Indeed, the 
anatomical intersection of CB1 receptors and FAAH enzyme 
supports the view that FAAH is placed for endocannabinoid 
levels regulation that could affect craving and reward behav-
iors over the pertinent neuronal circuitry and eventually the 
promotion of energy storage [40].
However, the discrepancies seen in different studies 
regarding the association of FAAH gene polymorphism 
with obese phenotype might stem from the fact that further 
gene–gene or gene–environment interactions are responsible 
in the obesity appearance and metabolic abnormalities and 
polymorphisms are not the sole contributing factors.
In summary, the frequency of A allele was greater in 
overweight/obese individual and mutation in FAAH gene 
was associated with higher anthropometric indices in Iranian 
women. This study provides additional support for periph-
eral endocannabinoid system role in obesity and associated 
comorbidities which could possibly help to detect the sub-
jects with a genetic susceptibility to obesity whom might 
gain advantage from primary prevention approaches. How-
ever, to improve the precision of our study, larger samples 
and further information about the metabolic and environ-
mental factors which control the FAAH gene expression is 
required.
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